Researchers from the Quebec Heart & Lung Institute at Laval University offered concepts to consider when selecting candidates for redo-TAVR and reviewed updated data on complication rates and clinical outcomes. Attilio Galhardo, Marisa Avvedimento, Siddhartha Mengi, and Josep Rodes-Cabau’s complete manuscript is available in the Journal of Clinical Medicine. Below is a summary of their review….
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest
Sponsored Links
